Jump to content

Hamburg Investor

Member
  • Posts

    88
  • Joined

  • Last visited

1 Follower

Recent Profile Visitors

14,737 profile views

Hamburg Investor's Achievements

Enthusiast

Enthusiast (6/14)

  • One Year In
  • Dedicated
  • Collaborator
  • One Month Later
  • Week One Done

Recent Badges

1

Reputation

  1. Thank you and thank you @SafetyinNumbers and @gfp. I mixed up different things, all clear now. Thanks!
  2. Thank you! Really appreciate helping us (me) learning. What I don’t get: And the dividends received itself just disappear from the balance sheet (so Viking has to adjust) But why? What’s the inherent logic? I mean it doesn’t feel accurate in the sense, that what’s hapenning is more like shifting something you own from one pocket into another, while the balance sheet just perceives the pocket with less in it. I thought the idea of the balance sheet was putting on record all pockets.
  3. Bought my first shares in 2013. Held them and added until 2018. It became my third biggest position until than (10% or so). Than had to reduce my portfolio in May 2020 (I needed money for buying our home) by nearly a third and reduced every stock but Fairfax (it went just too cheap) and even added a tiny bit. In April 2023 I added (and reallocated ) big at 900 CAD and it became my biggest position by far from around 10% to around 30%. This year Fairfax Financial grew to over 50%. Reduced it in October to 40%; today it‘s around 42%. It was a drag long term but it never felt wrong even in the bad years. I regularly look at my stocks, but when doing that I always felt FFH being a longterm winner, like I think about BRK and MKL. Mkl was one of my best performing stocks since 2011; that changed in the last years. BRK was my first stock, when „really“ beginning to invest (2007). It‘s interesting to watch that movie - sometimes one really outperforms the others than the other. Sometimes insurance stocks were really unloved; now that changed a bit. One does bad investments, the other looses traction in the insurance business, one buys Apple bug and wins, than sells a lot of businesses on the stock market… But over the long run the different strategies all seems to win; of course float helps. And having a value investor as manager helps.
  4. Anyway - 1% in any given months is a lot. Great!
  5. Why do you think 50% being reasonable this year? My best guess for your performence guess is that you add Momentum + undervaluation + good business numbers from quarter to quarter + an add to the TSX60 altogether. Am I right or wrong? But what, if the market crashes or interest would go down (to be clear: which I am NOT saying will happen; what I am saying is just, that I don’t believe anybody being able to predict if interest goes up or down or stays where it is)? I think everything is possible from minus 40% (if the market crashes 50% - why not?) to a double in price (e. g. if stock markets go up 50% and the market falling in love with insurance stocks in general or everything of the above happening). So why do you think it „should“ go up 50%? How do you get to a pe ratio of 10 after that? I assume you mean a pe ratio on the basis of normalized earnings and take 20% roe? At 1,4 pb ratio that‘s a pe ratio of 7 today, 50% growth in price in 12 months would be a pe ratio of 10 than (without counting in the returns / growth in business value over that time frame).
  6. A big thank you @Viking, @Parsad and all the others here and to the Fairfax team of course. I‘ve never been as sure in an investment as in Fairfax over the last years and I am still sure about it, being around 43% of my stock portfolio at yearend (and I am always fully invested, only long). My portfolio gave a return of 42% (after tax and cost) in 2024 and although not everything from the outperformance came from Fairfax, the majority of it came from it. Looking out over the next 5 years I expect a return of no less than a double, and if not in share price, than at least in intrinsic value (and that’s with a big margin of safety). My best guess is a threefold in intrinsic value and more in price (including dividends). Any stock market crash in the meantime would dampen return in price of FFH and pushing its CAGR of intrinsic value up, as I am sure FFH would find very good use for its cash than. But better than that: I expect Fairfax to be an outperformer not only over the next 5 years, but over the (very) longterm. And that’s what really matters at least to me, having no place to hide from tax (in Germany we don’t have tax free accounts - including spread, cost and tax you pay nearly a third jumping from one investment to the next one). All the best to everyone here and to your families! Have a good start to 2025 - greetings from Hamburg, Germany
  7. I voted a 9 for the following reasons: 1. I think of FFH as a learning company. So I don't give too much credit for the mistakes they made after 2009 - that's the past 2. After that mistakes I don't see bad decisions, but a lot of good ones: Expanding the insurance business and becoming a worldwide insurance company, business/stock decisions (the pet insurance business, greek and irish investments etc.) and the improvement in quality of the insurance business (relatively better cr in comparison to the market after 2011) etc. etc. - that was really, really good. 3. 1 and 2 alone would have led me to vote a 8 (maybe 7). But the TRS and - more - the astonishing manner in which Bernard has managed fixed-income investments in recent years (going short before interest rates went up) is simply phenomenal in my view. I'd expect that going down to a 7 or 8 over the years (you can't always be top top.
  8. It wasn‘t like that; I had to sell a lot of my portfolio (a quarter or so) in 2020, as I bought a house. But I sold other stocks and sticked to FFH. In 2022 and 2023 I got new funds and shifted others from to FFH. I should have shifted earlier (2020) from e.g. BRK to FFH.
  9. I agree about the sellers being longterm shareholders. But who were the buyers? Maybe also longterm shareholders? Both could be right.
  10. @Viking Are you sure, that this happened a lot? Is this something, we could see e. g. here at cobf? I am not so sure. (Btw: We should all give a lot of credit to you and the others posting a lot here, if that hasn‘t happened to the readers here. I learned a lot, thank you!) I bought my first FFH shares over a decade ago and it did it mostly, as I saw a lot of similarities between BRK (which I bought first), MKL (which I bought some years later) and FFH (which I bought last and added a lot, when it became cheap). So I didn’t buy FFH as a value investment, it just became a value investment (and a turnaround investment) as an addition to the GARP idea, when its business underperformed and the prices dropped to the low levels of 2021, 2022 and 2023. But at the core my general thesis always was that of FFH being a GARP quality investment with a longterm roe of 15% or more. Then the bad years came, but I always sticked to it, as I believed in management and thought of the lost decade as a phase. So I sold nothing. And following this board (which is of course not mirroring the average FFH shareholder in many ways - but still) I haven‘t got the impression, that a lot of people look(ed) at FFH as some kind of cigar butt value investment first line. I wouldn‘t be surprised, if a lot of people bought FFH with a similar view, so with the idea, that growth would come back. Then most of the trading we saw over the last 10+ years maybe wouldn‘t be „real people“, but computer, algorithmic, automated driven. Counting the latter out maybe over the years until 2022 or 2023 the „real people“ weren’t largely Value, but GARP oriented (with a longterm view of course) and longterm shareholders. Then those shareholders loaded up just more stocks, when they became cheap. A lot of us seem to have a big part of their portfolio in FFH - maybe no coincidence, cause maybe this is not only a function of stock returns over the last years, but more a combination with „old shareholders“ loading up more in the cheap years. But this doesn‘t make those buyers/holders value investors - they have been growth investors with the luck of buyibg really cheap. For me FFH now is 45% of my portfolio and it would be 55%, if I wouldn‘t have sold a bit a months ago. Had you asked me 5 years ago, with the excetion of BRK I wouldn‘t have thought of me owning any stock as being more than 10%, maybe 15% of my portfolio. And now I have FFH three or four tines that much - and I am not the only obe. It just happened, as FFH developed so good, the stock got that cheap and there weren’t a lot other good investments. So maybe there weren’t so much value investors involved in FFH historically, and since 2022 or so, there maybe are „new real people“, buying stocks from algorithmic driven sellers with a momentum view and some (few), that followed the stock or are understanding insurance stocks and now look at the numbers and understand, that something exceptional is going on. I have no idea, how one could evaluate that topic, if there are/were value investors engaged and who owns FFH today with what view - other than within this board, people sharing their view and the surveys here. Would be interesting to see, what you, @Viking and others think!
  11. Wouldn‘t it be a tailwind for the shortterm pricing, but a headwind for the longterm? - If price gets higher and less volatile, buybacks are less good investments (cheaper is better) - So buybacks get less attractive. So either Prem buys back at a more expensive price (which is less good then it be for intrinsic value then it would be without being added) or he doesn’t at all, as the price gets too high (which is less good for intrinsic value then it would be without being added). Paraphrasing Buffett from memory: As long as you are not a seller of stock, but a buyer, (what you are, if the business you hold shares of buys back stocks) cheaper prices are always better. Who thinks, Berkshire shareholders would be better off today, if BRK would have been added to the Dow 20+ years ago? (Maybe that’s another reason, why BRK never splitted the A shares…)? If you don’t think that would have helped BRK, why do you think, for FFH it would be?
  12. Thank you very much, I agree on your points. It‘s late here in Germany, but with the resonance here, we should open a discussion separate, I think (happy, that others are interested too in this discussion!) One thing came up in my mind; maybe we should focus more on the term „intrinsic value“; as you write here, at high roe companies, the iv tends to go up in value fast; I tend to agree, but than I think, if nothing really changed to the business, but iv moves up e. g. 30% from year 1 to year 2 (so 30% roe - let‘s say over decades), than iv can‘t be estimated right in year 1… But one gets to absurd levels e. g. of BRK, when you discount its value back from today to the 1970ies. And looked back from that perspective, BRK should have bought back a lot of more own stocks at every price there was, as the discount was just so absurd… But it didn‘t happen, Buffett hasn‘t bought back. But okay, let’s talk about that somewhere else…
  13. Thank you! That makes sense to me. That seems perfectly reasonable and understandable to me, logical. Just one comment: I have always found Munger and Buffett to be very forceful in their assertion that buybacks above intrinsic value are ‘capital-destroying’. But is that really the case? Isn't that oversimplifying? One example: Now let's imagine a company with a sustainable ROE of 40%. Munger would say, ‘No matter at what price you get in here, over a very long time horizon you will get roughly the ROE (assuming everything is reinvested in the company).’ And now let's assume that management buys significantly above intrinsic value, so that the repurchased shares ‘only’ yield 35% (instead of 40% as ROE is 40%) in the long run. I find Munger's judgement that (all) share buybacks above intrinsic value are always ‘capital-destroying’ somehow questionable. By the way, it can't be both ways: Either you get a return over the long term roughly in line with the ROE, regardless of the purchase price for the shares (in other words, regardless of whether you bought above or below intrinsic value), or purchases above intrinsic value are always ‘capital-destroying’. Or would anyone disagree that an average return of 35% per year for most of us doesn't exactly fit the definition of ‘value destruction’? To stay with the image: management would reinvest the surplus with a return of 35%; you have to achieve that yourself first (many of us would also have to pay tax on the dividends first; so we would have to achieve above 35% just to match the management). But that's how I read your formula, @nwoodman: Share buybacks above intrinsic value do not destroy capital; they only lead to lower returns than the company's ROE. In other words, companies with very high ROEs can buy back a large amount of shares above intrinsic value, and yet these are still sensible buybacks (unless you have better reinvestment opportunities). You can also turn it around: If a company with a ROE of 10% buys back shares below intrinsic value, the share buybacks will hardly achieve such a high return for the investor, as in the first example. But how can that be, if Munger is right. For the investor holding both stocks (50/50), it would be better to have the company with a 40% ROE buying back shares (slightly) above intrinsic value than to have the other company with a 10% ROE buying back shares below intrinsic value. In the best case (assuming these are the only two stocks available), the 10% ROE company pays a dividend and the investor uses that to buy more shares of the 40% ROE company, even at a 35% CAGR return. This way, the better company would come to dominate the investor's portfolio more and more. Or am I wrong?
  14. I plan to sell my stocks, when retiring regularly ("4% rule" - so step by step); hopefully in around 7 years. I'd sell/reduce Fairfax before in the following cases: 1. if I feel the need for diversification, which I just did, as FFH was near 50% and the weighting of the insurance within my portfolio pushed above 67%. So I sold MKL and FFH and bought some small caps I like. I think I begin not feeling comfortable, if FFHs at its current valuations is above 50% of my portfolio and if less than a third of my portfolio isn't insurance (while 10% is BRK and I like it for the float, but I don't see BRK as an insurance company with stocks and wholly owned businesses, but more like a fund of different businesses, including insurance). 2. A function of 1 is, if Fairfax outperforms my other investments by a lot and pb ratio grows e. g. into the direction of 2, than a. the concentration of my portfolio in FFH grows and at the same time b. my hunger for such a concentrated bet would go down a bit (maybe to a maximum of 30% or 40% of the portfolio), so I probably would sell step by step and buy other things. 3. if I find something much more compelling as a bargain (e. g. sustainable roe around 30% or above in the small cap world) and Fairfax is much more expensive in comparison. 4. if valuation gets absurd (minimum pb ratio of 3.0, maybe 5.0. 5 if the insurance sector gets structurally into a crisis or disrupted (something like "AI is disturbing the moat of BRK, MKL, FFH, which I don't see).
  15. @Viking Thank you for your answer, which I really appreciate, but I think I haven't made my question clear: 1.There's a roe on the surface, let's call that "face roe". But - as you pointed out and I totally agree - that's understated. 2. So you come up with an adjusted ROE on the basis of FV. That's 19%. 3. Okay, nice. now we have it. As Munger said many times (from memory) "If you have a business with a roe of 20% and you hold it over decades, your return will be roughly 20% - regardless, if you over- or underpay! In other words, if we have the adjusted roe, we know how the intrinsic value grows over time. Perfect, no more questions! But... No... wait?! We forgot the buybacks! Even over 2 decades there's clearly a big difference, between two businesses, where: BUSINESS A never bought back any stock nor sold out any dividends etc. and BUSINESS B, which bought back 99.9% of all stocks outstanding (okay... that never happens, I know ... but I want to illustrate my point... so let's just say for a moment 999 of 1.000 stocks have been bought back). So here you have it, that's my question: How can we take your "adjusted ROE" one step further to get to a number that shows the "growth of intrinsic value per share" (let's call that "givps"). It clearly must be above 19% - but where exactly? My thinking begins with something like: If in a given year we have 19% roe and 5% of stocks are bought back in that year I just divide 19% through 0.95 and get 20%. So the buyback activity would translate a roe 19% into a "givps" of 20% in that specific year. And if you buy back 5% of stocks in the next year and you have a roe of 19% again - is "givps" then 20% or 21% in the second year? I tend to the latter, as now I'd have to divide 19% through 0.9025. But is it just as simple? I don't think so, as e.g. buybacks above book value disturb the "e" in ROE. But how do we adjust the "e"quity back? And the growth in intrinsic value can't be agnostic to the price being paid for the stocks in the process of buybacks, but my simple formula ignores the price. And then we all know, that buybacks at a price below intrinsic value create new value, while above they destroy it ... Maybe it's just not possible to take that step from roe to "givps", not even roughly?! And maybe my idea is just wrong and I am just having knots in the head and I write nonsense here?
×
×
  • Create New...